# Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

> **NCT05663749** · PHASE4 · COMPLETED · sponsor: **All India Institute of Medical Sciences, Bhubaneswar** · enrollment: 60 (actual)

## Conditions studied

- Metabolic Syndrome
- Schizophrenia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Topiramate

## Key facts

- **NCT ID:** NCT05663749
- **Lead sponsor:** All India Institute of Medical Sciences, Bhubaneswar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-20
- **Primary completion:** 2023-07-30
- **Final completion:** 2023-08-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663749, "Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05663749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*